TTrialPathMatch Me to Trials
← Back to trials
RecruitingChronic Kidney Disease (Stages 4 and 5)Kidney DiseaseType 2 Diabetes

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

Sponsor: Well Cell Global

You may qualify if…

  • ✓ Is age 18 or older (male or female)
  • ✓ Have a documented diagnosis of CKD stage 3b, 4, or 5 and T2DM of 6 months or greater prior to screening. Patients may have treatment regimens associated with T2DM that include diabetic oral and/or injectable medications including insulin and/or GLP-1 receptor agonists.
  • ✓ In the opinion of the Investigator, has been on an appropriate, stable regimen for management of any complications present for the past six (6) months.
  • ✓ In the opinion of the Investigator, is able to do all of the following:
  • ✓ Provide valid informed consent.
  • ✓ Understand and comply with study procedures as presented in the consent process.
  • ✓ Has the capacity or support to attend all required visits.
  • ✓ If female, the subject must meet either of the following sets of conditions:

You may not qualify if…

  • ✕ Has in the past two (2) years received treatment for a malignancy.
  • ✕ Current pregnancy or intends to become pregnant during the study
  • ✕ Has in the past one (1) year used non-prescription opioids or psychoactive drugs.
  • ✕ Has in the past six (6) months had a hypoglycemic event requiring urgent care and/or administration of glucagon, osteocalcin, or parenteral glucose, unless approved for enrollment by the Medical Monitor.
  • ✕ Has within the past one (1) month participated in a clinical study involving either of the following:
  • ✕ An investigational drug or procedure for any clinical indication
  • ✕ An investigation method for glucose control using approved agents
  • ✕ Is nursing or is planning to nurse during the study.

Where it's recruiting

Arizona

Phoenix

Source: ClinicalTrials.gov · NCT07187479 · last updated 2025-10-20

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With · TrialPath